Boosted by a recent dose of funding, Carmel-based Confluence Pharmaceuticals is taking aim at Phase 2 clinical trials for its drug, which company leaders believe will restore hope and unlock potential... Read More
Chest pain is the second most common reason people rush to the emergency room (ER), but only one in five patients is actually having a cardiac event. The vast majority of people with chest pain are se... Read More
A $37.6 million grant is powering a newly-formed consortium tasked with developing DNA-encoded antibodies, which can kill a COVID-19 infection faster than antibody treatments that don’t have the power... Read More
A new study is now underway for bamlanivimab; retrofitted RVs will travel to the diverse state of New Mexico to turn any location into, essentially, a clinical research facility on wheels.... Read More
An Indiana University researcher has long been concerned about the cumulative effect of more elusive injuries for young people: subconcussive head impacts.... Read More
You can do good business and also do ‘Good’: that’s the theory behind a new Cook Medical facility that will bring 100 new jobs and free education to a struggling Indianapolis community.... Read More
Purdue University’s Dr. Philip Low, already a legend in Indiana’s life sciences sector after founding and selling Endocyte for $2 billion, is well on the path toward his next potential “game-changer.”... Read More
s schools scramble to stop the spread of COVID-19, classrooms are typically the main focus, while perhaps a more threatening setting is an afterthought: the school bus.... Read More
Friendship could be as beneficial for the mind as it is for the heart; scientists at Indiana University have already uncovered this.... Read More
While some sectors are weathering crippling economic effects from the pandemic, the state’s life sciences industry is flourishing, and recently inked two major business deals for central Indiana.... Read More
